Crystallization of 4′-epidaunorubicin hydrochloride
View Patent ↗4′-epidaunorubicin hydrochloride is provided in a crystalline form which is stable and readily soluble. A process of producing the crystalline form includes crystallizing 4′-epidaunorubicin hydrochloride in a solvent system including (a) solvent A selected from C 1 and C 2 halogenated solvents and mixtures thereof, (b) solvent B selected from C 1 -C 5 straight and branched alcohols and mixtures thereof, and (c) solvent C selected from C 1 -C 5 straight and branched alcohols and mixtures thereof, wherein solvent C is selected to provide lower solubility to 4′-epidaunorubicin hydrochloride than solvent B.
1. A process for producing crystalline 4′-epidaunorubicin hydrochloride comprising crystallizing 4′-epidaunorubicin hydrochloride in a solvent system including:
a) solvent A which is selected from the group consisting of C 1 and C 2 halogenated solvents and mixtures thereof;
b) solvent B which is selected from the group consisting of C 1 -C 5 straight and branched alcohols and mixtures thereof; and
c) solvent C which is selected from the group consisting of C 1 -C 5 straight and branched alcohols and mixtures thereof, wherein solvent C is selected to provide lower solubility to 4′-epidaunorubicin hydrochloride than solvent B, wherein the process comprises steps of:
dissolving 4′-epidaunorubicin hydrochloride in a solvent mixture I comprising (i) solvent A and (ii) solvent B or C to form a solution; and
contacting the solution with a solvent mixture II comprising solvents B and C.
2. The process according to claim 1 , wherein the solvent system comprises 0.1-20% by volume of solvent A, 7-50% by volume of solvent B and 45-92% by volume of solvent C.
3. The process according to claim 2 , wherein the solvent system comprises 1-6% by volume of solvent A, 10-40% by volume of solvent B and 54-89% by volume of solvent C.
4. The process according to claim 1 , wherein solvent mixture I comprises (i) solvent A and (ii) solvent B or C in a volume ratio between 1:2 and 4:1.
5. The process according to claim 1 , wherein upon contacting solvent mixture I with solvent mixture II, the solvent system comprises 0.1-20% by volume of solvent A.
6. The process according to claim 1 , wherein a concentration of 4′-epidaunorubicin hydrochloride in the solvent system is between 7 g/l and 30 g/l.
7. The process according to claim 1 , wherein dissolution of 4′-epidaunorubicin hydrochloride in solvent mixture I is performed at a temperature in the range between 40-80° C.
8. The process according to claim 7 , wherein after contacting the solution of 4′-epidaunorubicin hydrochloride with solvent mixture II the resulting mixture is cooled to a temperature in the range of 5-35° C.
9. The process according to claim 1 , wherein solvent A is selected from the group consisting of chloroform and dichloromethane.
10. The process according to claim 1 , wherein solvent B is selected from the group consisting of methanol, ethanol and 1-propanol.
11. The process according to claim 1 , wherein solvent C is selected from the group consisting of 1-butanol, isopropanol, isobutanol, and 1-pentanol.
12. The process according to claim 1 , wherein the solvent system consists of solvents A, B and C.